Stem cell treatment for recovering sports professionals


Bioscience Americas has created Bioscience High Performance (BHP), to offer stem cell treatment to American sports professionals.

The Phoenix, Arizona, group has plans for several adult stem cell treatment centres in Latin America, as they cannot open legally in the USA.

BHP will focus on professional athletes and sports teams in the USA, Canada, and across Latin America. It sees huge potential in using stem cell treatment on athletic injuries such as orthopaedic impairments, and muscle and ligament strains and tears.

Eric Stoffers of Bioscience Americas says, “Stem cell therapies have proven successful for many professional athletes during their playing years. Many retired athletes have also been treated with stem cell to help heal old sports injuries.”

Bioscience Americas is the international development partner of the Global Institute of Stem Cell Therapy and Research (GIOSTAR). GIOSTAR is a consortium of stem cell scientists based at the University of California Medical Centre in San Diego, California.

Bioscience Americas and GIOSTAR are jointly developing a stem cell treatment centre within San Vicente Hospital in Medellin, Colombia. Two stem cell centres in South America will follow this. Future expansion plans also include locating hospital related treatment facilities in Costa Rica and Mexico, and on Native American tribal land within the United States.



Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.


Related News

Bahamas stem cell therapy

02 October, 2020

Insolvency for stem cell clinic

Stem cell therapy risks

18 August, 2020

Injuries from stem cell therapy widespread

Inbound travel to Hong Kong

01 May, 2020

Hong Kong open in July, for Chinese tourists

Improving European cross-border healthcare

24 April, 2020

Ensuring timely access to advanced therapies in Europe

Costa Rica promotes stem cell treatment

23 October, 2019

Costa Rica looks to be stem cell treatment destination